Canine babesiosis in France

Vet Parasitol. 2006 May 31;138(1-2):118-25. doi: 10.1016/j.vetpar.2006.01.046. Epub 2006 Feb 28.

Abstract

Canine babesiosis has a high prevalence in France and continues to constitute a diagnostic challenge. This paper presents essential data derived from epidemiological surveys in order to define the main features of this disease. Atypical forms are frequent, the diagnosis must be confirmed by blood smears and treatment is based on the use of imidocarb. Prophylaxis currently remains insufficient.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiprotozoal Agents / administration & dosage
  • Antiprotozoal Agents / therapeutic use
  • Arachnid Vectors / parasitology
  • Arachnid Vectors / physiology
  • Babesia* / classification
  • Babesiosis / drug therapy
  • Babesiosis / epidemiology
  • Babesiosis / prevention & control
  • Babesiosis / veterinary*
  • Dermacentor / parasitology
  • Dermacentor / physiology
  • Dog Diseases / drug therapy
  • Dog Diseases / epidemiology*
  • Dog Diseases / parasitology
  • Dog Diseases / prevention & control
  • Dogs
  • Endemic Diseases / veterinary*
  • France / epidemiology
  • Geography
  • Imidocarb / administration & dosage
  • Imidocarb / therapeutic use
  • Prevalence
  • Protozoan Vaccines / administration & dosage
  • Protozoan Vaccines / immunology
  • Rhipicephalus sanguineus / parasitology
  • Rhipicephalus sanguineus / physiology
  • Vaccination / veterinary

Substances

  • Antiprotozoal Agents
  • Protozoan Vaccines
  • Imidocarb